FA
Fred Aslan (President and CEO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Artiva Biotherapeutics, Inc. (ARTV). The largest single filing was $690K of ARTV (61,888 sh × $11.16, as filed), executed Sep 3. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Nov 2
Filed Nov 3
Median ADV $6.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
ARTVRecent filings
ARTVSALE
Artiva Biotherapeutics, Inc.
View filing →
$260K62,178 sh × $4.18
Exec Nov 2
Filed Nov 3 · 4:04 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $169K
23,463 sh × $7.20
Exec Oct 6
Filed Oct 7 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $422K
61,696 sh × $6.84
Exec Oct 5
Filed Oct 6 · 4:01 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $256K
23,429 sh × $10.92
Exec Sep 8
Filed Sep 9 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $690K
61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET ARTVSALE Artiva Biotherapeutics, Inc. View filing → $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET